Shen-Ling-Bai-Zhu-San alleviates Crohn's disease-like colitis by modulating fatty acid degradation via the peroxisome proliferation-activated receptor pathway

An integrated approach combining network pharmacology, microbiomics, metabolomics, proteomics, and experimental validation

Bibliographic Data

ID14741987
AuthorsLinlin Zheng (0000-0002-8902-1056, China Medical University), Anqi Cui, Ai‐Li Cui (0000-0003-3288-6291, China Medical University), Jianing Shang (China Medical University), Fu Liu (0000-0003-1461-9608, China Medical University), Xiaoyu Zhang (0009-0003-2430-5001, China Medical University), Xue Dou (0000-0002-8991-5447), Xia Dou (0000-0001-9316-4466, China Medical University), Jieyu Liu (0000-0001-8330-5376, China Medical University, corresponding author), Yunwei Li (0000-0002-5410-4505, First Hospital of China Medical University, corresponding author)
Year2025
Volume353
IssuePt B
Pages120460
Publication date2025-09-01
Open AccessYes
TypeARTICLE
VenueJournal of Ethnopharmacology (JOURNAL)
Journal identifiersISSN: 0378-8741 • E-ISSN: 1872-7573
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.jep.2025.120460
PMID40848907
OpenAlexW4413388215
LanguageEN
References cited61

Tools

Open DOI